GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Vimta Labs Ltd (NSE:VIMTALABS) » Definitions » YoY EBITDA Growth

Vimta Labs (NSE:VIMTALABS) YoY EBITDA Growth : -14.55% (As of Dec. 2023)


View and export this data going back to 2005. Start your Free Trial

What is Vimta Labs YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Vimta Labs's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was -14.55%.

Vimta Labs's EBITDA per Share for the three months ended in Dec. 2023 was ₹10.10.


Vimta Labs YoY EBITDA Growth Historical Data

The historical data trend for Vimta Labs's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vimta Labs YoY EBITDA Growth Chart

Vimta Labs Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26.76 -45.39 68.54 46.67 21.02

Vimta Labs Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41.75 5.45 0.91 -26.45 -14.55

Vimta Labs YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Vimta Labs's YoY EBITDA Growth for the fiscal year that ended in Mar. 2023 is calculated as:

YoY EBITDA Growth (A: Mar. 2023 )
=(EBITDA per Share (A: Mar. 2023 )-EBITDA per Share (A: Mar. 2022 ))/ | EBITDA per Share (A: Mar. 2022 ) |
=(42.83-35.392)/ | 35.392 |
=21.02 %

Vimta Labs's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (Q: Dec. 2023 )
=(EBITDA per Share (Q: Dec. 2023 )-EBITDA per Share (Q: Sep. 2022 )) / | EBITDA per Share (Q: Sep. 2022 )) |
=(10.097-11.816)/ | 11.816 |
=-14.55 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vimta Labs YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Vimta Labs's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Vimta Labs (NSE:VIMTALABS) Business Description

Traded in Other Exchanges
Address
Plot No.141/2 & 142, IDA, Phase-II, Cherlapally, R. R. District, Hyderabad, TG, IND, 500051
Vimta Labs Ltd is a comprehensive contract research and testing organization, providing a wide range of services to pharmaceutical, biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device, and many other industries. Its services portfolio includes testing and contract research services in the fields of clinical research, pre-clinical research, clinical diagnostics, biopharma services, analytical testing, and research and environmental studies. The group generates principal revenue from the provision of testing and analysis services.

Vimta Labs (NSE:VIMTALABS) Headlines

No Headlines